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Abstract
Radiotherapy is commonly used as a cytotoxic treatment of a wide variety of tumors. Interestingly, few case reports
underlined its potential to induce immune-mediated abscopal effects, resulting in regression of metastases, distant
from the irradiated site. These observations are rare, and apparently depend on the dose used, suggesting that dose-
related cellular responses may be involved in the distant immunogenic responses. Ionizing radiation (IR) has been
reported to elicit immunogenic apoptosis, necroptosis, mitotic catastrophe, and senescence. In order to link a cellular
outcome with a particular dose of irradiation, we performed a systematic study in a panel of cell lines on the cellular
responses at different doses of X-rays. Remarkably, we observed that all cell lines tested responded in a similar fashion
to IR with characteristics of mitotic catastrophe, senescence, lipid peroxidation, and caspase activity. Iron chelators (but
not Ferrostatin-1 or vitamin E) could prevent the formation of lipid peroxides and cell death induced by IR, suggesting
a crucial role of iron-dependent cell death during high-dose irradiation. We also show that in K-Ras-mutated cells, IR
can induce morphological features reminiscent of methuosis, a cell death modality that has been recently described
following H-Ras or K-Ras mutation overexpression.
Introduction
Radiotherapy is widely used for cancer treatment and
although it can target both normal and cancerous cells,
fractionated radiotherapy using repeatedly low doses per
fraction limits damage to the normal tissue1. Therefore, a
standard radiotherapy regimen using daily doses of
around 2 Gy over 5–7 weeks is used in many tumor types
(National Comprehensive Cancer Network Guidelines).
Yet, several studies reported that repeated irradiation with
a low dose can induce a chronic inflammation, while high
doses boost the immune system2,3. Recent technological
advances enable delivering high dose per fraction (in
fewer fractions, i.e. hypofractionation) with minimal
damage to the surrounding tissue. Nonetheless, further
investigation is needed to shift the standard of repeated
low dose to high-dose treatment.
Ionizing radiation (IR) induces direct damages to the
DNA causing single- or double-strand breaks (SSBs,
DSBs). Nevertheless, around 70% of the DNA damage is
actually caused by free radicals generated following
the ionization of water in the cells4. These events engage
the DNA damage response (DDR) pathway, and while the
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SSBs are readily repaired, around 5% of DSBs fail to be
repaired and thus ultimately lead to cell death5. Due to
their higher replication rate and defects in the DDR
pathway, cancer cells are more susceptible to succumb to
IR as compared with normal cells. Following DNA
damage, cell cycle checkpoints stop cycle progression
preventing replication of damaged DNA. Depending on
the cell cycle phase during IR, radiosensitivity and
mechanisms leading to cell cycle arrest are different6.
When DNA damage occurs prior or during mitosis, cells
undergo mitotic catastrophe, and as a consequence
become binucleated and are not able to complete their
cycle7. Eventually, these cells may become senescent or
die through apoptosis or necrosis7,8.
As mentioned above, IR generates free radicals9. Among
them, reactive oxygen species (ROS, such as hydroxyl
radical HO• or hydrogen peroxide H2O2) are produced
from oxygen metabolism, are toxic at high levels and can
damage DNA, lipids, and proteins9,10.
Many studies described several types of cell death following
IR, such as apoptosis, necrosis, and more recently necrop-
tosis, a RIPK3/MLKL regulated type of necrosis11–13. These
cell death modalities have a distinct outcome on the immune
system. While necrosis and necroptosis are more inflam-
matory14,15, apoptosis is considered a less immunogenic cell
death modality. Several reviews suggested that while low
doses IR would induce apoptosis, a higher dose would trigger
necrosis11,16, suggesting that a low dose would be non-
immunogenic, in contrast to a high dose.
The literature concerning IR-induced cell death is
confusing, and results differ substantially depending on
the cell line, or the dose. Systematic studies are lacking
where different types of cells and IR doses are rigorously
compared. We investigated the induction of regulated cell
death mechanisms (apoptosis, necroptosis, ferroptosis)
and cellular stress responses (mitotic catastrophe, senes-
cence) by different doses of IR. We included a panel of
murine cell lines of distinct origins (lung adenocarcinoma,
cervical cancer, colon cancer, and fibrosarcoma). All the
cell lines tested responded similarly to different doses of
IR and exhibited dose-dependent caspase activity, features
of mitotic catastrophe and senescence. Cancer cells also
underwent lipid peroxidation that could be prevented by
iron chelators (but not by free-radical traps17,18) that
additionally inhibited IR-induced cell death, implying a
crucial role for free iron-dependent cell death.
We also found that IR induced morphological features
of methuosis in K-Ras-mutated cell lines (hereafter
referred as methuosis). Methuosis is a cell death modality
recently characterized occurring following expression of
H-Ras or K-Ras mutation (G12V)19,20. It is characterized
by massive vacuolization in the cytoplasm. These vacuoles
are formed by macropinocytosis and instead of being
normally recycled, fuse with each other. In a late phase of
methuosis, cells detach and their membrane become
permeabilized, without showing apoptotic features21.
Ras is frequently mutated in cancer, with K-Ras being
the most prevalent mutation, present for example in 90%
of pancreatic tumors22. In cancer patients, the presence of
K-Ras mutations is frequently assessed and radiotherapy
is often part of the proposed treatment23. Exploring the
role of methuosis during radiotherapy is thus highly
relevant.
Results
Ionizing radiation-induced immune protection
We tested whether as previously suggested11,16, a
high-dose IR would be immunogenic, as opposed to a
low dose. We performed prophylactic vaccination
experiments with two cell lines commonly used in
immunogenicity studies, the colon cancer cells CT26
and the fibrosarcoma cells MCA205. Cells were irra-
diated with a high dose (50 Gy), and with a lower dose IR
(20 Gy) before subcutaneous injection into the flank of
BALB/c or C57BL/6 mice. Although the extent of cell
death was minimal at the time of injection (around 20%
Sytox Blue positive Fig. 1b, d), the irradiated cells did
not generate tumors at the vaccination site. Cells irra-
diated with doses lower than 20 Gy continued to grow
in vivo, generating tumors on the vaccinated site (data
not shown), thus invalidating the experiments per-
formed with lower doses24. Cells irradiated with either
20 or 50 Gy were efficient in inducing an immune pro-
tection (Fig. 1a, c), and no statistical difference was
observed between the two IR doses, in opposition with
the abovementioned hypothesis.
Induction of cell death by single-dose ionizing radiation in
cell lines with altered cell death pathways
One study reported the induction of necroptosis fol-
lowing radiation13. To evaluate whether in our experi-
mental setup irradiated cells could undergo a necroptotic
cell death modality, we used necroptosis proficient
MLKL+/+ L929sA and MLKL+/+ MEFs as well as their
deficient counterparts (MLKL−/− L929sA and MLKL−/−
MEFs). L929sA cells were resistant to IR and did not
undergo a significant increase in cell death as measured by
Sytox Green uptake at any tested IR dose (Fig. 2a, b). We
also did not find caspase activation as measured by
DEVDase activity (Fig. 1a, b, right axes). Cell death
increased when MLKL+/+ L929sA were exposed to IR
doses in the presence of zVAD-fmk and was completely
absent in MLKL−/− L929sA (Fig. 2b), suggesting that it
was necroptosis (Fig. 2a). Treatment with caspase inhi-
bitor alone resulted in low levels of cell death, in line with
a previous report25.
Both MLKL+/+ and MLKL−/− MEF cells were sensitive
to IR-induced cell death, especially at doses of 10 Gy and
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more (Fig. 2c, d). To investigate the cell death modality
induced, we used zVAD-fmk (apoptosis), Nec1s
(necroptosis), and Fer-1 (ferroptosis). Nec1s is an inhi-
bitor of RIPK1 kinase affecting both RIPK1 kinase-
dependent apoptosis and necroptosis26. To document a
possible switch from apoptosis to necroptosis (or vice
versa), we also included a combination with both zVAD-
fmk and Nec1s (Fig. 2c, d). Caspase activation was not
detected in these cell lines (Fig. 2c, d, right axes). The
absence of protection by Nec1s on cell death in MEF
suggests that RIPK1 is not implicated. We also used
RIPK1−/− MEF cells stably reconstituted with RIPK1-
venus to visualize RIPK1 complex formation, quantified
by the number of spots per area of cytoplasm with high-
content imaging (Fig. S1). IR effectively induced cell death
in these cells (dose-dependent decrease of the number of
cells and increase in PI+ cells). No increase in the for-
mation of RIPK1-venus dots was observed, while it clearly
was in the necroptotic control (hTNF+Taki+ zVAD-
fmk). These results show that a wide range of IR doses did
not induce necroptosis neither in L929sA nor in MEF
cells. Only in the presence of zVAD-fmk, L929sA
underwent necroptosis, induced by increasing IR doses,
an artificial situation of caspase-8-inhibition. To investi-
gate the contribution of intrinsic apoptosis in IR-induced
cell death we used Bax/Bak−/− and Bax/Bak+/+ MEF
cells (Fig. 2e, f and Fig. S4b). Irradiated MEF cells deficient
for Bax and Bak were resistant to cell death, suggesting
their involvement in IR-induced cell death. ACSL4−/− and
ACSL4+/+ MEF cells (called Pfa1) were used to determine
the contribution of ferroptosis in IR-induced cell death.
The enzyme Acyl-CoA Synthetase Long-Chain Family
Member 4 (Acsl4) catalyzes the conversion of long-chain
fatty acids to their active form and is implicated in the
synthesis of unsaturated long-chain fatty acids that are
target for lipid peroxidation during ferroptosis. Cells
lacking ACLS4 are resistant to ferroptotic cell death27. We
did not observe a difference in the sensitivity to IR-
induced cell death between these two MEF cell lines (Fig.
2g, h). These results prompted us to extend our study to
investigate the effect of IR doses on a wider set of cancer
cell lines.
Fig. 1 Prophylactic vaccination with high-dose irradiated cells (20 or 50 Gy) induce immune protection in mice. CT26 and MCA205 cells were
irradiated with 20 or 50 Gy the day before the vaccination. PBS or cells irradiated with 20 and 50 Gy were injected subcutaneously in Balb/c. After
7 days, the mice were injected on the opposite flank with living cells. Tumor growth was monitored every 2 days up to 35 days post-challenge.
Percentage of tumor-free mice after vaccination with irradiated CT26 cells and MCA205 cells are shown in a and c, respectively. The extent of cell
death measured as Annexin V positivity (AnnV), Sytox Blue (SB) positivity, and a combination of the two was minimal at the time of injection and is
shown in b (CT26 cells) and in d (MCA205 cells).
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Single dose and fractionated IR-induced cell death in
cancer cell lines
We tested the effect of increasing IR doses on four cancer
cell lines from different origins: CT26 colon carcinoma,
MCA205 fibrosarcoma, 71-7 KrasG12D;p53−/− lung adeno-
carcinoma, and the Murine Uterine Cervix Cancer (MUCC)
cells. CT26, MCA205, and 71-7 showed a significant increase
in IR-induced cell death from a dose of 10Gy on (Fig. 3a–c),
while the MUCC cells were not sensitive to IR-induced cell
death at any of the IR doses tested (Fig. 3e). No inhibition of
cell death was observed when pre-treated with either zVAD-
fmk, Nec1s or Fer-1, or a combination thereof. We observed
an IR dose-dependent increase in caspase activity in these cell
lines. While zVAD-fmk could block the activity of caspases,
no impact on cell death by plasma membrane permeabili-
zation was observed, suggesting that the cells may continue
to die by another cell death modality, different from
necroptosis and bona fide ferroptosis. These results are in
line with a recent study showing that zVAD-fmk could not
protect against IR-induced cell death28. A clonogenic assay
performed on 71-7 cells showed a complete cytostatic effect
of IR at high doses (Fig. 3d), suggesting that cells lost their
capacity to grow. We also performed a series of clonogenic
assays with these four cancer cell lines and the same cell
death inhibitors (Fig. S2a–d). While Nec1s, zVAD, and Fer-1
could rescue cell death induced by mTNF (necroptosis),
staurosporine (apoptosis), and ML162 (ferroptosis), respec-
tively (Fig. S2e), they did not rescue irradiated cells, in line
with our results that other cellular stress and cell death
modalities may be implicated.
Fractionated IR regimens are commonly used in the
clinic and we tested whether repeated irradiation on the
cells would induce higher levels of cell death and whether
apoptosis, necroptosis, or ferroptosis would occur. Cell
death slightly increased in MLKL+/+ and MLKL−/−
L929sA after fractionated IR compared to single doses
(Fig. S3a, b). CT26, 71-7, and MUCC cells were more
sensitive to fractionated than to single high IR dose (Fig.
S3) and died significantly after being irradiated on three
consecutive days with small doses such as 2 Gy (for CT26
and MUCC) and 3.3 Gy (71-7 cells) (Fig. S3c–e). As for
single-dose IR, zVAD-fmk, Nec1s, or Fer-1 could not
prevent the cell death induced, although zVAD-fmk could
block caspase activity.
Ionizing radiation induces features of mitotic catastrophe
Mitotic catastrophe is a cellular response that senses
mitotic failure and drives cells to an irreversible anti-
proliferative fate leading to cell death or senescence29. As
such, mitotic failure does not constitute a pure execu-
tioner cell death pathway but rather a cellular stress
response following a mitotic defect as a consequence of
IR. We sought to determine whether features of mitotic
catastrophe would be present to a similar extent across all
the IR doses examined. Following DNA damage, cells can
fail to complete their mitotic cycle and this results in the
presence of multiple nuclei and micronuclei. Nuclear
morphology (area and roundness) and micronuclei for-
mation were assessed by high-content imaging in irra-
diated MCA205, 71-7, and MUCC cells (Fig. 4a, b, e, f, i, j).
Presence of micronuclei, irregular nuclear shape, and area
increased with increasing IR doses (Fig. 4c, g, k). Cell size
also increased in an IR dose-dependent way (Fig. 4d, h, l).
These features were independent of p53 expression (p53
is expressed in MCA205, but not in MUCC and 71-7, Fig.
S1). Together, these results show that increasing IR doses
induce features of mitotic catastrophe, such as micro-
nucleation, altered nuclear morphology, and multinuclei
formation in three different cancer cell lines.
IR-induced senescence
As mentioned above, mitotic catastrophe lead to cell
death or senescence. The flat and enlarged morphology
of cells following high-dose IR suggested a state of
senescence. We performed a flow cytometry staining
with a fluorescent β-galactosidase substrate, Annexin V
and Sytox Blue, markers for phosphatidylserine expo-
sure and membrane permeabilization, respectively.
Flow cytometry histograms (Fig. 5a, e, i) show an IR
dose-dependent increase in β-galactosidase activity for
both CT26 and 71-7, while the increase was milder for
MCA205. This is also reflected in the histograms
showing the quantification of positive cells for
β-galactosidase (Fig. 5b, f, j and d, h, l). We observed a
dose-dependent increase of cells positive for both
β-galactosidase and for the apoptotic marker Annexin
V (Fig. 5d, h, l), suggesting that part of the senescent
cells may eventually undergo apoptosis. These three
cell lines showed caspase activity following IR (Fig.
(see figure on previous page)
Fig. 2 Cell death induction by single-dose ionizing radiation in cells with altered cell death pathways. a–d Cell death and caspase activity
were measured 72 h after IR at the indicated doses by Sytox Green and Ac-DEVD-amc fluorescence in MLKL+/+ L929sA (a), MLKL−/− L929sA (b),
MLKL+/+ MEF (c), MLKL−/− MEF cells (d), Bax/Bak+/+ MEF (e), and Bax/Bak−/− MEF (f), ACSL4+/+ Pfa1 (g), and ACSL4−/− Pfa1 (h). When indicated, the
cells were pre-treated for 1 h with zVAD-fmk, Nec1s or Fer-1, or a combination thereof. Histogram bars show Sytox Green positivity and lines indicate
caspase activity (fold induction). Means ± SEM are shown (n= 2–3). A two-way ANOVA was performed with a Tukey’s multiple comparisons test.
Asterisk (*) shows the comparison to 0 Gy DMSO. Hash (#) shows the comparison to the DMSO treatment for the respective irradiation dose. *,#p ≤
0.05, ##p ≤ 0.01, ***, ###p ≤ 0.001, ****,####p ≤ 0.0001.
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3a–c), and here we also found an IR dose-dependent
increase in apoptotic cells (Annexin V+/ Sytox Blue−)
(Fig. 5c, g, k).
Ionizing radiation-induced lipid peroxidation and iron-
dependent cell death
We then investigated whether several cell lines
exhibited lipid peroxidation following irradiation. We
used the lipid peroxidation sensor, C11-Bodipy (508/
591), which undergoes a shift in fluorescence when
oxidized. All cell lines tested (CT26, MCA205, 71-7)
revealed an increase in lipid peroxidation 24 h after
high-dose IR (20 and 50 Gy) (Fig. 6a–c). We compared
the effect of lipophilic antioxidants (Fer-1, Vitamin E)
or iron chelators (CPX, DFO) on lipid peroxidation as
demonstrated in the context of ferroptosis17,18,30.
Fig. 3 Cell death induction by single-dose ionizing radiation. a–c, e Cell death and caspase activity were measured 72 h after IR at the indicated
doses by Sytox Green and Ac-DEVD-amc fluorescence in CT26 (a), MCA205 (b), 71-7 (c), and MUCC (e). When indicated, the cells were pre-treated
with zVAD-fmk, Nec1s or Fer-1, or a combination thereof. Histogram bars reflect Sytox Green intensity and lines describe caspase activity (fold
induction). d Clonogenicity assay performed on 71-7 cells at different IR doses. Means ± SEM are shown (n= 2–3). A two-way ANOVA was performed
with a Tukey’s multiple comparisons test. Asterisk (*) shows the comparison to 0 Gy DMSO. *p ≤ 0.05, **,##p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
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Fig. 4 Induction of multinucleation and micronucleation by ionizing radiation. Nuclear morphology was quantified through high-content
imaging in MCA205 (a–d), 71-7 (e–h), MUCC (i–l) cells, 48 h after irradiation. Cells were stained with Hoechst and propidium iodide after
permeabilization to allow segmentation of the nucleus and cytoplasm, respectively. Nuclear area was measured in MCA205 (a), 71-7 (e), and MUCC
(i). The roundness of the nucleus was also assessed after irradiation in MCA205 (b), 71-7 (f), and MUCC (j). Percentage of cells with micronuclei is
shown for MCA205 (c), 71-7 (g), and MUCC (k) cells. The area of the cells was also measured following irradiation in MCA205 (d), 71-7 (h), and MUCC
(l) cells. m Representative picture of micronuclei segmentation. n Representative picture of segmentation mask for the assessment of the
nuclear shape.
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Interestingly only iron chelators, but not lipophilic
free-radical traps, were able to block IR-induced lipid
peroxidation and cell death induced by 20 and 50 Gy
irradiation, suggesting that cell death was iron-
dependent.
Ionizing radiation induces features of methuosis
By careful observation of the cellular morphology by
microscopy, we detected the presence of large vacuoles
visible in bright field and translucent in phase contrast.
Such vacuoles are a feature of methuosis, a cell death
Fig. 5 Ionizing radiation induces senescence. Senescence induction was measured 72 h following irradiation at the indicated doses by flow
cytometry with C12FDG, a β-galactosidase substrate emitting fluorescence upon its cleavage. Co-staining with Annexin V-APC and Sytox Blue was
performed to indicate apoptosis and membrane permeabilization, respectively, in CT26 (a–d), MCA205 (e–h), and 71-7 (i–l) cells. Representative flow
cytometry histograms are shown for C12FDG (SA-β-Gal) staining in CT26 (a), MCA205 (e), and 71-7 (i). Percentage of cells positive for C12FDG (SA-
β-Gal) and/or Sytox Blue is shown for CT26 (b), MCA205 (f), and 71-7 (j) cells. Percentage of cells positive for Annexin V-APC and/or Sytox Blue is
shown for CT26 (c), MCA205 (g), and 71-7 (k). Percentage of cells positive for C12FDG (SA-β-Gal) and/or Annexin V-APC is shown for CT26 (d),
MCA205 (h), and 71-7 (l). Means ± SEM are shown (n= 2). SA-β-Gal senescence-associated β-Galactosidase.
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Fig. 6 (See legend on next page.)
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modality triggered by Ras(G12V) activating mutation (H-
Ras or K-Ras)20,31. We performed sequencing of K-Ras in
our cell lines and found the G12D mutation in CT26 cells
(Fig. 7a), according to the literature32. The activating
mutation K-Ras(G13R) was found in the MUCC cells (Fig.
7d). No K-Ras mutations were found at position 12 or 13
in MCA205 and 71-7 cells (Fig. 7b, c). The latter result
was unexpected, since 71-7 cells are derived from K-
RasG12D, p53−/− mouse tumors33. Significant increases
in methuosis following irradiation were found in the two
K-Ras mutated cells, CT26 and MUCC (Fig. 7a, d). These
two cell lines show a low percentage of methuosis in non-
irradiated condition, as could be expected from their
active K-Ras mutation (Fig. 7a, e). In cell lines without K-
Ras mutations (71-7 and MCA205), sporadic cells with
methuotic features were also observed following irradia-
tion (Fig. 7b, c, movies), suggesting that this process might
also occur independently of K-Ras mutations (none of the
cell lines had an H-Ras mutation at codon 61; data not
shown). We followed the cells for 96 h after irradiation
(Movies 1–4, Supplemental Material) and found mor-
phological features of apoptosis (blebbing) in all the cell
lines tested, presence of necrotic cells in CT26 and
MCA205, and features of methuosis in CT26, MUCC, and
71-7 (Fig. S6a–d).
Discussion
We show that in a panel of distinct cancer cell lines
(colon, cervical, lung adenocarcinoma, fibrosarcoma), the
cellular response to various regimens of irradiation was
remarkably similar in a dose-dependent fashion. We
observed a dose-dependent increase in caspase activity,
mitotic catastrophe, senescence, and lipid peroxidation.
We also found an increase in the presence of large
translucent vacuoles that resemble methuosis in K-ras
mutated cells.
Altogether, our observations are at odds with widely
spread paradigms that low dose IR would eventually elicit
apoptosis, while high dose would result in accidental
necrosis11,16. We detected a dose-dependent increase in
caspase activity and Annexin V+ cells after IR, and we
could also observe apoptotic morphology (blebbing) by
microscopy. However, while caspase activity could be
blocked with the caspase inhibitor (zVAD-fmk), such
treatment could not prevent cell death, suggesting that it
might be overruled by another parallel cell death pathway.
Caspase activation was shown to prevent release of type I
interferon, which is involved in IR-induced immuno-
genicity34,35. Low levels of caspase activation following IR
might allow for type I interferon release, explaining the
immunogenicity observed. MEF cells lacking Bax and Bak
were resistant to IR-induced cell death, suggesting that
these pro-apoptotic proteins are important in this process.
Earlier studies showed that when cells overexpressed Bax
or Bak, treatment with zVAD-fmk could prevent caspase
activation but was unable to inhibit cell death36,37, similar
with our observation. Activation of Bax following irra-
diation seems to be essential to drive cell death through
the mitochondria. In contrast, caspase activation seems to
be optional for cell death to occur, as cells continue to die
by other cellular stress mechanisms and cell death
modalities.
Necroptosis was shown to be induced following IR with
RIPK1 inhibitor Necrostatin-1 (Nec1) reducing the sur-
vival fraction cancer cells13. Here, necroptosis occurred
only in the MLKL proficient L929sA, which was already
shown upon addition of zVAD-fmk through autocrine
TNF production25. None of the other cells line underwent
necroptosis, even in the presence of zVAD-fmk, although
the 71-7 and MEF cells exhibited an intact necroptotic
pathway (expression of RIPK1 RIPK3 and MLKL). We
conclude that in these cell lines, necroptosis is not the
main cell death modality in response to IR.
ROS and free radicals produced following IR can react
with lipids and generate lipid peroxides. Lipid peroxida-
tion was shown to drive ferroptosis38 and cell death that
can be inhibited by both iron chelators and antioxidants is
termed ferroptosis39. Iron chelators can inhibit ferroptosis
by preventing iron from donating electrons to oxygen,
thereby preventing the formation of reactive oxygen
species (ROS). Ferrostatin-1 and vitamin E are lipophilic
inhibitors of ferroptosis which function as free-radical
traps for peroxidized phospholipids30,40. Cell death and
lipid peroxidation occurring following high-dose IR could
only be blocked by iron chelators (DFO, CPX), but not by
lipophilic free-radical traps, suggesting an alternative
iron-dependent cell death modality different from bona
fide ferroptosis.
(see figure on previous page)
Fig. 6 Ionizing radiation induces lipid peroxidation and an iron-dependent type of cell death. a–c Measurement of lipid peroxidation using
C11-BODIPY probe and cell death using Sytox Blue in CT26 (a), MCA205 (b), and 71-7 (c) cells 24 h after irradiation with 20 or 50 Gy. Increase in lipid
peroxidation can be seen in the first left quadrant by the shift of C11-BODIPY fluorescence measured after 20 Gy (blue) or 50 Gy (red) X-rays. When
indicated, the cells were pre-treated with iron chelators CPX and DFO, or with antioxidants vitamin E and Fer-1 1 h before irradiation. Quantification
of cell death is shown as percentage for CT26 (a), MCA205 (b), and 71-7 (c). Means ± SEM are shown (n= 2–3). A two-way ANOVA was performed
with a Tukey’s multiple comparisons test. Asterisks (*) show the comparison to 20 Gy Methuosis. *p ≤ 0.05, **p ≤ 0.01.
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Radiolysis of water generates hydroxyl radical (HO•) or
hydrogen peroxide (H2O2). Cell death induced by IR
resembles H2O2-induced cell death, which cannot be
rescued by the antioxidant Fer-1, while it is by iron che-
lators41. A recent study found that IR triggers ferroptosis
by inhibition of low levels of lipid peroxidation induced by
6 Gy radiation with the antioxidant Ferrostatin-1 (ref. 42).
It is possible that Fer-1 could cope with the low levels of
lipid peroxidation induced by 6 Gy, as opposed to
the higher levels of lipid peroxidation seen with 20 or
50 Gy.
We also observed enhanced features of methuosis in
cells expressing mutated K-Ras following IR. Cells that did
not express K-Ras mutant showed only a minor presence
of cells with vacuoles, suggesting that some of the
vacuoles would be formed in a K-Ras-independent man-
ner. Interestingly, the oncogene K-Ras is also known to
induce senescence43. The relationship between senescence
Fig. 7 Ionizing radiation induces features of methuosis. Microscopic evaluation of the presence of phase-lucent vacuoles in CT26 (a), MCA205 (b),
71-7 (c), and MUCC (d) cells after 72 h irradiation with 20 Gy. An example of pictures for CT26 cells is shown in e. Means ± SEM are shown (n= 3). An
unpaired t-test was performed for the methuosis data. Asterisks (*) show the comparison to 0 Gy. *p ≤ 0.05, **p ≤ 0.01.
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and methuosis has yet to be established, but from our
microscopic analysis, we could see that part of the cells
undergoing methuosis first presented a flat and enlarged
morphology resembling senescence. Methuosis could be
an eventual cell death modality outcome of senescence.
Given the high prevalence of K-Ras mutation in different
types of cancers, it would be interesting to further evaluate
the importance of methuosis in the response to radio-
therapy and whether this represents an immunogenic cell
death modality or not.
We propose a model in which upon increasing doses of
IR, the cells are subject to an increasing amount of DNA
damage and ROS9. ROS further impacts on the damage of
the DNA and lipids, causing lipid peroxidation. The cell
cycle is halted and the DDR is activated to repair the
DNA, when possible. As evidenced by clonogenicity
assays, when cells are irradiated with doses lower than
10 Gy, most of the DNA breaks can be repaired and the
cells can resume their cell cycle, divide, and stay alive.
However, with doses higher than 10 Gy, several DSB
cannot be repaired. The next division round leads to
mitotic catastrophe, and cells exhibit multiple nuclei and
micronuclei. Cells in mitotic catastrophe can either die by
apoptosis or necrosis, or become senescent44. Bax and Bak
are implicated in IR-induced apoptosis, while blocking
caspase activation reveals necrotic cell death different
from necroptosis and bona fide ferroptosis. Senescent
cells could also proceed to undergo apoptosis or unre-
gulated necrosis45. Our findings demonstrate that neither
RIPK1-dependent cell death nor bona fide ferroptosis
occurs. Methuosis could be an outcome in K-Ras-mutated
cells. Ultimately, cells undergo an iron-dependent
necrosis associated with lipid peroxidation that cannot
be blocked by lipophilic free-radical traps, but only by
iron chelators (Fig. 8).
Materials and methods
Cell lines and reagents
MCA205 and 71-7 cells were cultured in RPMI sup-
plemented with 10% FCS, 2 mM L-glutamine, 0.4 mM
sodium pyruvate. MUCC cells were cultured in the same
medium, but with a 20% FCS concentration. CT26,
MLKL+/+ L929sAhFas (L929sA cells transfected with
hFas)46 (later referred to as L929sA cells), MLKL−/−
L929sA (generated by Crispr/Cas9, by Jolien Bridelance),
MLKL+/+ MEF, MLKL−/− MEF, and RIPK1-venus MEF
(generated by Maria Ladik) were cultured in Dulbecco’s
modified Eagle’s medium supplemented with 10% FCS,
2 mM L-glutamine, 0.4 mM sodium pyruvate. All cells
were maintained at 37 °C under 5% CO2 atmosphere.
MCA205 were obtained from Guido Kroemer (Centre de
Recherche des Cordeliers, Paris, France). 71-7 cells were
obtained from Eileen White (Rutgers Cancer Institute of
New Jersey, New Jersey, USA). MUCC cells were obtained
from Katrien Vandecasteele (Ghent University Hospital,
Radiotherapy Department, Ghent, Belgium). ACSL4−/−
and ACSL4+/+ MEF cells (called Pfa1) were a kind gift
from Marcus Conrad (Helmholtz Zentrum München,
Neuherberg, Germany). Cell lines were regularly tested
for mycoplasma.
zVAD-fmk (Bachem, Bubendorf, Switzerland) was used
at 20 μM; Necrostatin 1s (Nec1s) (synthesized by the
Laboratory of Medicinal Chemistry, University of
Antwerp) was used at 10 μM. Antioxidant Ferrostatin-1
(Fer-1) (Xcess Biosciences) was used at 10 μM; vitamin E
(α-tocopherol) (Sigma-Aldrich) was used at 100 μM. The
iron chelators DFO (Sigma-Aldrich) and Ciclopirox
Fig. 8 Cellular responses to ionizing radiation. Following X-ray
irradiation with doses ranging from 2 to 50 Gy, there is a dose-
dependent increase in ROS production, lipid peroxidation, and DNA
damage. As a result, the DNA damage response is activated and will
attempt to resolve the DNA breaks. In a case of low irradiation dose
(<10 Gy), cells manage to repair their DNA, and still retain their
capacity to proliferate. Cells with irreparable DNA that go into
replication will be stuck in the mitotic cycle and undergo mitotic
failure. Cells in a state of mitotic catastrophe will have several fates
depending on the extent of the nuclear abnormalities and on the
proteins expressed. Several outcomes of mitotic catastrophe seem to
co-exist, such as senescence, methuosis, necrosis (membrane
permeabilization), and activation of Bax, Bak, and caspases with
presence of apoptotic features. A part of the senescent cells might
become apoptotic (dotted arrow). K-Ras mutation can induce both
senescence and methuosis; however, a link between the two cell
states was never described. Here, we found that part of the large cells
with flattened morphology also had methuotic vacuoles, which might
indicate that methuosis could be an outcome of senescent cells
(dotted arrow). Ultimately, the cells will die out of an iron-dependent
type of cell death.
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olamine (CPX; Sigma-Aldrich) were used at 100 and
10 μM, respectively. Human TNF was used at 600 U/mL
and Tak1 inhibitor (Taki; Analyticon Discovery) at 1 μM.
For flow cytometry, Annexin V-APC (BD Biosciences)
was used at a 1:400 dilution and Sytox Blue (Molecular
Probes) was used at 1.3 μM. For Fluostar cell death assay,
Sytox Green (Molecular Probes) was used at 1 μM.
For western blot, the following antibodies were used:
anti-RIPK1, anti-RIPK3 (Sigma-Aldrich, R4277), anti-
MLKL (Millipore, MABC604), anti-caspase 3 (Cell Sig-
naling Technology, 9662), anti-caspase-8 (Abnova,
MAB3429), anti p53 (Cell Signaling Technology, 2524),
anti-b-tubulin-HRP (Abcam, ab21058), anti-Bax (Upstate
Biotechnology, 06-499), anti-Bak (Millipore, 06–536),
anti-ACSL4 (Santa Cruz Biotechnology, sc-271800).
X-ray irradiation of cells
Cells were irradiated using a clinical 6MV X-ray beam
produced by a linear accelerator Elekta Synergy® (Elekta
Crawley) at the Radiation Oncology Department (Uni-
versity Hospital Ghent, Ghent University). Source-to-
surface distance was 1 m; a 1.5 cm Perspex® plate was
used to compensate the build-up effect.
Prophylactic vaccination with irradiated cells
Female BALB/c (Charles River, France) or C57BL/6
(Janvier, France), 7- to 8-week-old were housed in a
pathogen-free facility in the animal facility of the IRC-VIB
Department. All animal study procedures were approved
by the ethical committee of Ghent University. CT26 and
MCA205 cells were irradiated with 20 or 50 Gy the day
before the vaccination. Mice were vaccinated with 3 × 106
irradiated CT26 subcutaneously on the left flank and were
then challenged with 5 × 105 live cells 7 days later on the
opposite flank. Vaccination with irradiated MCA205 cells
was performed with 3 × 105 cells and the challenge with
3 × 104 cells. Mice developing tumors at the vaccination
site were not included in the experiment according to the
immunogenic cell death guidelines47. The tumors were
measured using calipers every alternate day. Mice were
randomly assigned a cage and the outcome was assessed
blindly.
Analysis of cell death
Cell death was measured with a Fluostar Omega plate
reader (BMG Labtech, Ortenberg, Germany) as previously
described48. Cells were seeded in triplicate at 1000 cells
per well in 170 μL of medium in 96-well plates. Eight
hours later, the cells were pre-treated 30min with cell
death inhibitors zVAD-fmk, Nec1s, Fer-1 before being
irradiated at the indicated doses. At 48 h post-irradiation,
the cells were incubated for 1 h at 37 °C with 1 μM of
Sytox Green (Thermo Fisher scientific) and 10 μM of Ac-
DEVD-AMC (PeptaNova, GmbH, Sandhausen,
Germany). Sytox green intensity and caspase activity were
measured with a Fluostar Omega plate reader both after
48 and 72 h post-irradiation with ex/em filters of 485/
520 nm for Sytox Green and 360/460 nm for Ac-DEVD-
AMC. 0.1% Triton X-100 was used to permeabilize the
cells and obtain the maximal cell death for each well. Cell
death was calculated by subtracting the background
fluorescence from Sytox Green intensity, divided by the
maximal cell death subtracted from the background
fluorescence.
β-galactosidase staining for senescence
Murine cancer cell lines (71-7, CT26, and MCA205)
were cultured to ~80% confluence in 12-well plates and
subjected to X-ray irradiation at the doses mentioned.
Control non-irradiated (NI) cell lines were cultured to
equivalent confluence and handled in the same manner as
irradiated cells and control non-senescent (NS) cells were
freshly seeded the day before analysis at ~90% confluence.
Cellular senescence was assessed according to Debacq-
Chainiaux et al. (2009)49. Measurements were performed
72 h post-irradiation using flow cytometry. Bafilomycin
A1 (Sigma, 100 nM) was added for 1 h to induce
lysosomal alkalynization. This step was followed by 2 h
incubation with 5-dodecanoylaminofluorescein di-β-D-
galactopyranoside C12FDG, Thermo Fisher Scientific,
33 μM), a fluorogenic substrate for β-galactosidase activity
(Ex 490/Em 514). Once inside the cell, the C12FDG
substrate is cleaved by β-galactosidase producing a green
fluorescent product measured with the LSRII (BD Phar-
Mingen). The results were analyzed with FlowJo 10.4
Software (Treestar, Ashland, OR).
C11-Bodipy staining
Cells were seeded at 100,000 cells per well in 12-well
plates. Once adherent, the cells were pre-treated with the
lipophilic free-radical traps (Fer-1, Vit E) and iron che-
lators (DFO and CPX). The cells were then irradiated with
20 or 50 Gy. Twenty-four hours after irradiation, the cells
were harvested, washed with phosphate-buffered saline
(PBS), followed by staining with BodipyTM 581/591 C11
(Thermo Fisher Scientific, D3861) (2 μM final con-
centration) in PBS, at 37 °C in the dark for 10min. Cells
were then washed with PBS before being incubated with
Sytox Blue (1.25 μL final concentration) in PBS. Samples
were acquired with a BD LSRII flow cytometer (BD
Biosciences) and results were analyzed with FlowJo
10.4 software.
Clonogenicity assay
71-7 cells were irradiated at indicated doses. After 24 h,
500 cells were seeded per T25 flask. After 10 days, when
colonies are formed, cells were fixed with 4% PFA for
10min, washed twice with PBS, and subsequently stained
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with 0.01% crystal violet diluted in PBS for 1 h RT. Finally,
the cells were washed and dried overnight before imaging
with a Nikon microscope AZ100M. Colonies were
counted with Fiji.
Assessment of nuclear morphology
Nuclear morphology was assessed using an Operetta high-
content imager (PerkinElmer). Five thousand cells were
seeded in 96-well plates. Once adherent, the cells were
irradiated at the indicated doses. Forty-eight hours post-
irradiation, 3 μM Hoechst (Sigma-Aldrich and 1 μM propi-
dium iodide (Sigma-Aldrich) were added to the cells before
image acquisition with a ×20 objective. After acquisition, cells
were fixed with 4% homemade Paraformaldehyde (PFA) for
10min, and subjected again to the Operetta high-content
imager. Nuclear area, roundness, and cell area were assessed
with Colombus software (PerkinElmer). Segmentation masks
were made with Hoechst for the nucleus and for the cyto-
plasm with propidium iodide. The experiment involved
either three or four biological replicates and sub-sampling
with 18 technical replicates as sampling units.
Quantification of methuosis
The presence of phase-lucent vacuoles was assessed
with an Opera High-Content Imager (PerkinElmer). Two
thousand and five hundred cells were seeded in 96-well
plates. The next day, cells were irradiated with 20 Gy.
Cells were stained 72 h post-irradiation with 3 μM
Hoechst and 0.6 μM DRAQ7 (Biostatus, Leicestershire,
UK), before acquisition with a ×20 objective. The number
of nuclei and DRAQ7-positive cells was calculated with
segmentation masks using Columbus software (Perki-
nElmer). The number of cells with phase-lucent vacuoles
was determined manually.
For the movies examining cellular morphologies, 2000
cells were seeded per well in 96-well plates. The next day,
cells were irradiated with 20 Gy. Three hours after irra-
diation, 1 μM Sytox Green (Thermo Fisher Scientific) was
added to the cells and the plates were placed in an
Incucyte ZOOM platform, inside an incubator at 37 °C
with 5% CO2. Four ×20 magnification images from dif-
ferent areas per well were captured at 1-h interval with
phase contrast and green (800 ms exposure) channels for
up to 4 days post-irradiation. Each condition was run in
triplicates. Incucyte software’s processing definition was
used to generate representative images.
Statistical analysis of nuclear morphological data
A hierarchical generalized linear mixed model
(HGLMM) as implemented in Genstat v19 (VSN Inter-
national (2017), Genstat for Windows 19th Edition, VSN
International, Hemel Hempstead, UK. Web page: Genstat.
co.uk) was fitted to the data. Fixed terms included the
cell-type, the irradiation dose and their interaction;
random terms included the biological replicate, the plates
nested within the replicate and the subsamples nested
within the plate. In the case of cell area, nuclear area,
nuclear roundness and MN+ cells, an HGLMM was fitted
considering a normal distribution for both fixed and
random effects. In the case of number of objects and
number of micronuclei, a Poisson distribution of the fixed
effects and a Gamma distribution of the random effects
were considered. Significances of main and interaction
effects were assessed by a WALD test for dropping fixed
terms. T statistics were used to assess the significance of
specific fixed effects estimated as differences (on the
transformed scale) to a reference level (Gy= 0). Estimated
mean values were obtained as predictions from the
HGLMM, formed on the scale of the response variable.
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